[Development of Stevens-Johnson syndrome following sulindac administration in a patient with mixed connective tissue disease]
- PMID: 8256166
[Development of Stevens-Johnson syndrome following sulindac administration in a patient with mixed connective tissue disease]
Abstract
Nineteen-year-old woman with mixed connective tissue disease developed Stevens-Johnson syndrome following treatment of arthritis using sulindac. Involvements of infectious and malignant diseases have been ruled out and sulindac has strongly been suspected as a causative agent for Stevens-Johnson syndrome. Ten out of 13 cases with Stevens-Johnson syndrome associated with non-steroidal anti-inflammatory drugs, sulindac has been administrated. Four cases also presented with severe liver disease. Patients who developed Stevens-Johnson syndrome following sulindac administration did not have apparent common clinical or laboratory findings which might be implicated for development of this severe side effects. Among the various non-steroidal anti-inflammatory drugs, safety of sulindac has widely been appreciated. However, occurrence of severe adverse events as reported here indicated that sulindac should be administrated as carefully as other non-steroidal anti-inflammatory drugs.
Similar articles
-
Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.J Rheumatol. 1983 Jun;10(3):512-3. J Rheumatol. 1983. PMID: 6224935
-
Sulindac-induced Stevens-Johnson syndrome: report of 3 cases.J Rheumatol. 1981 Jan-Feb;8(1):176-9. J Rheumatol. 1981. PMID: 7218253 No abstract available.
-
Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome.JAMA. 1980 Mar 28;243(12):1262-3. JAMA. 1980. PMID: 7359684 No abstract available.
-
Stevens-Johnson Syndrome and cholestatic hepatitis.Dig Dis Sci. 2001 Nov;46(11):2385-8. doi: 10.1023/a:1012351231143. Dig Dis Sci. 2001. PMID: 11713940 Review.
-
Acute vanishing bile duct syndrome after ibuprofen therapy in a child.J Pediatr. 2004 Aug;145(2):273-6. doi: 10.1016/j.jpeds.2004.05.027. J Pediatr. 2004. PMID: 15289784 Review.